GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Market Cap

Allied Biotech (ROCO:1780) Market Cap : NT$1,568.2 Mil (As of Apr. 10, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Allied Biotech's share price for the quarter that ended in Dec. 2024 was NT$17.35. Allied Biotech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 95.6 Mil. Therefore, Allied Biotech's market cap for the quarter that ended in Dec. 2024 was NT$1,659.1 Mil.

Allied Biotech's quarterly market cap increased from Dec. 2023 (NT$1,582.2 Mil) to Jun. 2024 (NT$1,730.8 Mil) but then declined from Jun. 2024 (NT$1,730.8 Mil) to Dec. 2024 (NT$1,659.1 Mil).

Allied Biotech's annual market cap increased from Dec. 2022 (NT$1,340.2 Mil) to Dec. 2023 (NT$1,572.1 Mil) and increased from Dec. 2023 (NT$1,572.1 Mil) to Dec. 2024 (NT$1,659.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Allied Biotech's Enterprise Value for Today is NT$1,536.4 Mil.


Allied Biotech Market Cap Historical Data

The historical data trend for Allied Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Market Cap Chart

Allied Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,603.31 1,454.10 1,340.16 1,572.10 1,659.08

Allied Biotech Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,340.16 1,755.08 1,582.21 1,730.79 1,659.08

Competitive Comparison of Allied Biotech's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Biotech's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where Allied Biotech's Market Cap falls into.


;
;

Allied Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Allied Biotech's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=NT$17.35*95.624
=NT$1,659.1

Allied Biotech's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=NT$17.35*95.624
=NT$1,659.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Biotech  (ROCO:1780) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Allied Biotech Market Cap Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech Headlines

No Headlines